New transparency website launched by Bayer

In addition to summaries of safety-related study reports for a significant number of active substances, Bayer will start to enable non-commercial access to the respective safety-related study reports, starting with reports on imidacloprid.

Background material such as videos and infographics are also available to help put regulatory science into context.

Dr Adrian Percy, global head of research and development for the Crop Science division said: “As conflicting accounts about the safety of food or technologies are making it difficult for people to separate fact from fiction, this Bayer initiative is an important step towards increased transparency.

“By sharing safety data, which was previously only shared with authorities, we hope to connect the public with our scientific community in a way that builds trust and shows our desire to further create transparency.

“We are excited to launch our new website which also aims to support authorities around the globe by providing an alternative tool, other than filing freedom of information requests, for them to obtain the documents which underlie our registration procedures,”

said Dr Percy.

New Bayer website: cropscience-transparency.bayer.com/